Collegium Pharmaceutical(US:COLL) Hai Nan Ri Bao·2025-07-06 00:26Core Viewpoint - The introduction of a "zero tariff" policy for imported medical devices and drugs in the Boao Lecheng International Medical Tourism Pilot Zone is facilitating the rapid entry of advanced medical technologies and products, benefiting both domestic and international patients [2][3]. Group 1: Policy Implementation - The "zero tariff" policy for imported medical devices and drugs was officially implemented on December 25, 2024, following the issuance of management measures by the Hainan provincial government [3]. - The Lecheng Pilot Zone has successfully integrated multiple departments to streamline the application process for "zero tariff" imports, reducing the administrative burden on medical institutions [4][6]. Group 2: Clinical Applications - The first clinical use of the Nexa smart cochlear implant system occurred at the Tree Lan (Boao) Hospital, with 50 units purchased, valued at approximately 15 million yuan, resulting in over 1 million yuan in tax exemptions [2][4]. - As of July 5, 2024, approximately 50 surgeries have been completed using the Nexa system, showcasing the immediate impact of the new policy on patient care [2]. Group 3: Regulatory Innovations - A comprehensive tracking management platform has been established to facilitate the application for "zero tariff" imports, allowing medical institutions to submit requests without leaving the hospital [3][4]. - The platform has enabled real-time data sharing between customs and medical institutions, enhancing efficiency and reducing redundancy in the application process [4][6]. Group 4: Future Developments - Continuous optimization of the platform and mechanisms is planned to expand the range of eligible medical devices and drugs, aiming to maximize the benefits of the policy for a larger population [7].